$ARQT Cashflow Statement | Understand Stock

$ARQT

$31.68 -$0.13 (0.41%) Close

$ARQT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Non-cash lease expense
Stock-based compensation expense
Loss on disposal of property and equipment
Change in fair value of embedded derivative instrument
Amortization of intangible assets
Acquired in-process research and development
Non-cash interest expense
Net accretion on marketable securities
Other non-cash items, net
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued liabilities
Operating lease liabilities

Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of marketable securities
Proceeds from maturities and sales of marketable securities
Purchases of property and equipment
Acquisition of in-process research and development
Milestone payment for intangible asset
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of long-term debt
Proceeds from issuance of common stock upon exercise of stock options
Proceeds from issuance of convertible preferred stock, net of issuance costs
Proceeds from issuance of common stock for ESPP
Payment of financing costs
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
Proceeds from long-term debt
Proceeds from issuance of shares under ATM, net of issuance costs
Proceeds from initial public offering, net of issuance costs
Payment of debt issuance costs
Net cash provided by financing activities

Effect of exchange rate changes on cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Right-of-use assets obtained in exchange for operating lease liabilities
Reduction in right-of-use asset upon reassessment of lease term
Deferred financing costs included in accounts payable and accrued liabilities

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest expense paid in cash
Acquired in-process research and development in exchange for the issuance of common stock
Conversion of preferred stock to common stock and APIC

Comments